Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel‐group, double‐blind, placebo‐controlled trial

Abstract

We found no evidence that a standard dose of high purity Ginkgo biloba confers benefit in mild-moderate dementia over 6 months.